logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Cancer Biomarkers The Promises And Challenges Of Improving Detection And Treatment 1st Edition Diagnosis

  • SKU: BELL-2225636
Cancer Biomarkers The Promises And Challenges Of Improving Detection And Treatment 1st Edition Diagnosis
$ 31.00 $ 45.00 (-31%)

5.0

28 reviews

Cancer Biomarkers The Promises And Challenges Of Improving Detection And Treatment 1st Edition Diagnosis instant download after payment.

Publisher: National Academies Press
File Extension: PDF
File size: 1.37 MB
Pages: 251
Author: Diagnosis, and Treatment Committee on Developing Biomarker-Based Tools for Cancer Screening
ISBN: 9780309103862, 030910386X
Language: English
Year: 2007
Edition: 1

Product desciption

Cancer Biomarkers The Promises And Challenges Of Improving Detection And Treatment 1st Edition Diagnosis by Diagnosis, And Treatment Committee On Developing Biomarker-based Tools For Cancer Screening 9780309103862, 030910386X instant download after payment.

Many cancer patients are diagnosed at a stage in which the cancer is too far advanced to be cured, and most cancer treatments are effective in only a minority of patients undergoing therapy. Thus, there is tremendous opportunity to improve the outcome for people with cancer by enhancing detection and treatment approaches. Biomarkers will be instrumental in making that transition. Advances in biotechnology and genomics have given scientists new hope that biomarkers can be used to improve cancer screening and detection, to improve the drug development process, and to enhance the effectiveness and safety of cancer care by allowing physicians to tailor treatment for individual patients - an approach known as personalized medicine. However, progress overall has been slow, despite considerable effort and investment, and there are still many challenges and obstacles to overcome before this paradigm shift in oncology can become a reality.

Related Products